Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
+0.0005 (100.00%)
Apr 25, 2025, 2:02 PM EDT
IPIX Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2014 - 2018 |
| Cash & Equivalents | 0.86 | 1.52 | 3.81 | 10.19 | 6.02 | 0.58 | Upgrade
|
| Cash & Short-Term Investments | 0.86 | 1.52 | 3.81 | 10.19 | 6.02 | 0.58 | Upgrade
|
| Cash Growth | -70.89% | -60.13% | -62.66% | 69.39% | 939.38% | -76.11% | Upgrade
|
| Prepaid Expenses | 0.08 | 0.12 | 0.15 | 0.5 | 0.09 | 0.05 | Upgrade
|
| Total Current Assets | 0.94 | 1.63 | 3.95 | 10.69 | 6.11 | 0.63 | Upgrade
|
| Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
| Long-Term Investments | 3.74 | 3.81 | 3.98 | - | - | - | Upgrade
|
| Other Intangible Assets | 1.91 | 2 | 2.31 | 2.75 | 3.06 | 3.34 | Upgrade
|
| Long-Term Deferred Charges | - | - | 0.06 | 0.78 | - | - | Upgrade
|
| Other Long-Term Assets | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Total Assets | 6.67 | 7.52 | 10.38 | 14.3 | 9.25 | 4.05 | Upgrade
|
| Accounts Payable | 3.02 | 1.5 | 1.08 | 1.08 | 0.56 | 0.64 | Upgrade
|
| Accrued Expenses | 1.78 | 1.76 | 1.73 | 2.34 | 3.27 | 3.25 | Upgrade
|
| Short-Term Debt | 0.24 | 0.21 | 0.25 | 1.46 | 1.9 | 1.92 | Upgrade
|
| Current Portion of Leases | - | 0.06 | 0.2 | 0.17 | 0.14 | - | Upgrade
|
| Other Current Liabilities | 0.01 | 1.49 | 1.55 | 1.5 | 1.5 | 1.49 | Upgrade
|
| Total Current Liabilities | 5.05 | 5.02 | 4.81 | 6.54 | 7.37 | 7.3 | Upgrade
|
| Long-Term Debt | 0.46 | 0.46 | 0.79 | - | - | 0.88 | Upgrade
|
| Long-Term Leases | - | - | 0.06 | 0.25 | 0.42 | - | Upgrade
|
| Total Liabilities | 5.51 | 5.48 | 5.65 | 6.79 | 7.79 | 8.18 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 129.57 | 129.57 | 129.09 | 124.84 | 102.82 | 90.54 | Upgrade
|
| Retained Earnings | -126.21 | -125.33 | -122.16 | -115.12 | -101.24 | -94.6 | Upgrade
|
| Treasury Stock | -2.25 | -2.25 | -2.25 | -2.25 | -0.15 | -0.09 | Upgrade
|
| Shareholders' Equity | 1.16 | 2.04 | 4.73 | 7.51 | 1.46 | -4.13 | Upgrade
|
| Total Liabilities & Equity | 6.67 | 7.52 | 10.38 | 14.3 | 9.25 | 4.05 | Upgrade
|
| Total Debt | 0.7 | 0.73 | 1.29 | 1.87 | 2.46 | 2.8 | Upgrade
|
| Net Cash (Debt) | 0.17 | 0.79 | 2.52 | 8.32 | 3.56 | -2.22 | Upgrade
|
| Net Cash Growth | -90.24% | -68.52% | -69.73% | 133.63% | - | - | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | -0.01 | Upgrade
|
| Filing Date Shares Outstanding | 518.35 | 518.35 | 503.87 | 452.74 | 347.19 | 212.5 | Upgrade
|
| Total Common Shares Outstanding | 518.35 | 518.35 | 503.87 | 433.8 | 330.99 | 203.31 | Upgrade
|
| Working Capital | -4.11 | -3.39 | -0.86 | 4.15 | -1.26 | -6.67 | Upgrade
|
| Book Value Per Share | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 | -0.02 | Upgrade
|
| Tangible Book Value | -0.75 | 0.04 | 2.42 | 4.76 | -1.6 | -7.47 | Upgrade
|
| Tangible Book Value Per Share | -0.00 | 0.00 | 0.00 | 0.01 | -0.00 | -0.04 | Upgrade
|
Updated Nov 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.